You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Otorhinolaryngologic Neoplasms

Showing 1 - 25 of 546
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus

Recruiting
  • Head and Neck Cancer
  • +6 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, China
    Eye & ENT Hospital of Fudan University
Apr 13, 2023

Rehabilitation Nursing Program in Otolaryngology

Completed
  • Rehabilitation
  • +2 more
  • rehabilitation nursing
  • Évora, Portugal
    University of Évora
Feb 18, 2022

Oropharynx Cancer, Oropharynx Squamous Cell Carcinoma, Carcinoma, Squamous Cell Trial in Aarhus, Copenhagen, Odense (radiation,

Recruiting
  • Oropharynx Cancer
  • +18 more
  • Intensity-Modulated Radiation Therapy (IMRT)
  • +3 more
  • Aarhus, Denmark
  • +2 more
Sep 28, 2021

Doses Delivered During Image Guided Radiation Therapy Tests

Not yet recruiting
  • Lung Neoplasm
  • +4 more
  • 3D maps of physical doses
  • Levallois-Perret, Hauts-de-Seine, France
  • +8 more
Feb 17, 2022

Oropharynx Cancer Trial in Pittsburgh (procedure, other, radiation, drug)

Recruiting
  • Oropharynx Cancer
  • therapeutic conventional surgery
  • +5 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 4, 2022

The Myeloid Neoplasms Biology and Outcome Project

Recruiting
  • Myeloid Neoplasm
    • Heidelberg, Baden-Württemberg, Germany
      UHHeidelberg
    Nov 21, 2022

    True Exocrine Epithelial Pancreatic Cystic Neoplasms Based on

    Completed
    • Pancreas Cancer
    • surgical resection
    • (no location specified)
    Apr 22, 2022

    Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

    Recruiting
    • Digestive System Neoplasms
    • iNeo-Vac-R01
    • Hangzhou, Zhejiang, China
      Department of General Surgery, Institute of Minimally Invasive S
    Sep 8, 2023

    Biliary Tract Tumors Trial (Total Neoadjuvant Treatment)

    Not yet recruiting
    • Biliary Tract Neoplasms
    • Total Neoadjuvant Treatment
    • (no location specified)
    Sep 7, 2023

    Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging

    Recruiting
    • Neoplasms
    • Muscle Neoplasm
    • evaluate the quality of surgical margins achievable with the use of navigated Intraoperative CT
    • Rome, Italy
      "Regina Elena" National Cancer Institute
    Jun 15, 2023

    MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

    Recruiting
    • MDS/MPN
    • Azacitidine (AZA) with Ruxolitinib
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Apr 17, 2023

    Endoscopic Mucosal Resection With Circumferential Incision Trial in Moscow (Endoscopic mucosal resection with circumferential

    Active, not recruiting
    • Endoscopic Mucosal Resection With Circumferential Incision
    • Endoscopic mucosal resection with circumferential incision
    • Endoscopic submucosal dissection
    • Moscow, Russian Federation
      Elmira
    Jan 10, 2023

    Epidemiological and Clinical-pathological Factors of

    Completed
    • Myeloproliferative Neoplasm
    • +4 more
      • Guayaquil, Guayas, Ecuador
        Sociedad de Lucha Contra el Cáncer
      Apr 25, 2023

      Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)

      Recruiting
      • Digestive System Neoplasms
      • iNeo-Vac-R01 in combination with standard adjuvant therapy
      • Hangzhou, Zhejiang, China
        Department of General Surgery, Institute of Minimally Invasive S
      Sep 8, 2023

      Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

      Recruiting
      • Digestive System Neoplasms
      • iNeo-Vac-R01
      • Hangzhou, Zhejiang, China
        Department of General Surgery, Institute of Minimally Invasive S
      Sep 8, 2023

      CD70-positive Advanced Urologic Tumors Trial in Shanghai (Anti-CD70 CAR-T cells)

      Recruiting
      • CD70-positive Advanced Urologic Neoplasms
      • Anti-CD70 CAR-T cells
      • Shanghai, Shanghai, China
        Changhai Hospital
      Aug 11, 2023

      Myeloproliferative Tumors Trial in Canada, Spain, United States (VAC85135, Ipilimumab)

      Recruiting
      • Myeloproliferative Neoplasms
      • Birmingham, Alabama
      • +16 more
      Jan 27, 2023

      Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

      Active, not recruiting
      • Myeloproliferative Neoplasm
      • +4 more
      • Orange, California
        Chao Family Comprehensive Cancer Center, University of Californi
      Jan 6, 2023

      Myeloproliferative Tumors Trial (INCA033989)

      Not yet recruiting
      • Myeloproliferative Neoplasms
      • (no location specified)
      Sep 11, 2023

      GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

      Enrolling by invitation
      • GEP-NET
      • +3 more
      • Copenhagen, Denmark
        Rigshospitalet
      Jan 24, 2023

      Myeloid Tumor Trial in Memphis (CPX-351, MHA)

      Recruiting
      • Myeloid Neoplasm
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jan 20, 2023

      TEXTBOOK OUTCOME IN ADRENAL NEOPLASMS

      Completed
      • Outcome Assessment
      • Adrenal Neoplasm
      • Adrenalectomy
      • Alicante, Spain
        Juan Jesús Rubio García
      May 24, 2023

      Mature B-cell Tumors Trial (Nemtabrutinib)

      Not yet recruiting
      • Mature B-cell Neoplasms
      • (no location specified)
      Jan 13, 2023

      Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory Chronic Myelomonocytic Leukemia, Relapsed or Refractory

      Recruiting
      • Relapsed or Refractory Acute Myeloid Leukemia
      • +2 more
      • Duarte, California
      • +1 more
      Mar 14, 2023

      EBV-associated Lymphomas Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell

      Not yet recruiting
      • EBV-associated Lymphomas
      • (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
      • (no location specified)
      May 31, 2023